Institute of Immunology and Immunotherapy Immunology is at the forefront of medical research and we are among the leaders of this exciting, fast-evolving field.
News £17.9m for Advanced Therapy Treatment Centre network to bolster UK clinical trial infrastructure The network includes the Midlands-Wales Advanced Therapy Treatment Centre, jointly delivered by University of Birmingham and University Hospitals Birmingham.
News BactiVac Network awarded £700k by the UK Vaccine Network Project to focus on potential epidemics
30 January 2024 New appointment: Dr Shivan Sivakumar Dr Shivan Sivakumar, a nationally recognised oncologist in cancers of the pancreas, liver and biliary tract, joins the College of Medical and Dental Sciences.
15 December 2023 Research Fellow receives five-year £706K Wellcome Trust Early-Career Award Dr Sally Clayton will study a novel pathway that becomes dysregulated in inflammatory diseases and how it controls the function in immune cells.
12 December 2023 Funding boost supports tackling bacterial infections worldwide through collaborative innovation New funding, announced by the Medical Research Council, will support BactiVac, the Bacterial Vaccines Network as well as other global vaccine research.
07 November 2023 Promising target for liver disease treatments identified Inhibiting a protein involved in liver inflammation has the potential to reduce or stop fibrosis in patients with non-alcoholic steatohepatitis, trial finds
30 October 2023 New inflammatory mechanisms unveiled in the setting of liver disease and liver cancer For the first time, researchers have shown a direct link between a blood vessel protein and cell growth arrest in the liver
28 September 2023 BactiVac funded to develop bacterial vaccines in global fight against antimicrobial resistance The University of Birmingham-hosted BactiVac Network secures major funding to accelerate the development of bacterial vaccines.
02 August 2023 Study screening young people for diabetes expanded across Europe Parth Narendran, Professor of Diabetes Medicine, has been awarded £860K funding towards type 1 diabetes general population screening of young people in Europe.